We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Takes Legal Action Against HHS Over 340B Drug Discounts
Novartis Takes Legal Action Against HHS Over 340B Drug Discounts
Novartis has become the latest pharma company to sue HHS over its threats to levy financial penalties against drugmakers who hold back 340B drug discounts from contract pharmacies, an effort that’s won a preliminary injunction against the fines for now.